Ȩ »çÀÌÆ®¸Ê   ¿µ¹®   Áß¹®

È«º¸¼¾ÅͰøÁö»çÇ×
°Ô½ÃÆÇ ¸®½ºÆ®
  ÁÖÁÖ¿©·¯ºÐµé²² ¾Ë·Áµå¸³´Ï´Ù. °ü¸®ÀÚ 2020-12-18 4603
  ÁÖÁÖ¿©·¯ºÐµé²² ¾Ë·Áµå¸³´Ï´Ù. °ü¸®ÀÚ 2020-12-17 5165
  ÁÖÁÖ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù. °ü¸®ÀÚ 2020-10-26 6649
  ÁÖÁÖ ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù. °ü¸®ÀÚ 2020-09-22 7309
  IR ÀÚ·á (Corporate Overview) °ü¸®ÀÚ 2020-08-11 7039
  ¼¼Æ÷Ä¡·áÁ¦ »ý»ê¿ë Á¦2°øÀå ½Ä¾àó Çã°¡ °ü¸®ÀÚ 2020-06-24 5946
  °³¹ßÁßÀÎ Á¦Ç° ÁøÇà°èȹ (±¹¹®º») °ü¸®ÀÚ 2020-06-24 5526
  °³¹ßÁßÀÎ Á¦Ç° ÁøÇà°èȹ °ü¸®ÀÚ 2020-06-23 4529
  ÁÖÁÖ ¿©·¯ºÐ²² ¾Ë·Á µå¸³´Ï´Ù. °ü¸®ÀÚ 2020-06-17 5517
  ÁÖÁÖ ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù °ü¸®ÀÚ 2020-06-10 4753
  302 ÀÓ»ó½ÃÇè Àç°³ °ü¸®ÀÚ 2020-06-09 6630
  ALLO-ASC-SheetÀÇ ¹Ì±¹ FDAÀÇ RMAT ÁöÁ¤ÀÇ ÀÇ¹Ì °ü¸®ÀÚ 2020-05-25 6934
  ÷´Ü Àç»ýÀÇÇÐ Ä¡·áÁ¦ (Regenerative Medicine Advanced Therapy)¶õ? °ü¸®ÀÚ 2020-05-25 3934
  Company Policy for Expanded Access to Investigational (Unapproved) Drugs °ü¸®ÀÚ 2020-05-21 4737
  ´ç´¢º´¼ºÁ·ºÎ±Ë¾çÄ¡·áÁ¦, ¹Ì FDA·ÎºÎÅÍ Ã·´ÜÀç»ýÀÇÇÐÄ¡·áÁ¦(RMAT)·Î ÁöÁ¤½ÂÀÎ °ü¸®ÀÚ 2020-05-20 4687
  Genetic Engineering & Biotechnolgy News º¸µµ³»¿ë °ü¸®ÀÚ 2020-05-07 4027
  ÁÖÁÖ¿©·¯ºÐ²² ¾Ë·Áµå¸³´Ï´Ù. °ü¸®ÀÚ 2020-04-06 6206
  ºÎ±¤¾àǰ º¸À¯ ÁÖ½Ä ÁöºÐÀ² º¯µ¿ °ü·Ã °ü¸®ÀÚ 2020-03-27 3749
  Á¦ 20±â ÁÖÁÖÃÑȸ °ü·Ã ¾È³»»çÇ× °ü¸®ÀÚ 2020-03-18 2457
  ¹Ì±¹ Wagner grade II ÀÓ»ó ½ºÅ¸Æ® °ü¸®ÀÚ 2020-03-16 3700
1|2|3|4|5|6|7|8|9|10